메뉴 건너뛰기




Volumn 94, Issue 1, 2005, Pages 8-11

Cross-reactivity of cyclooxygenase 2 inhibitors in patients with a history of cutaneous reactions to cyclooxygenase 1 inhibitors

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHISTAMINIC AGENT; CELECOXIB; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; IBUPROFEN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; ROFECOXIB; VALDECOXIB;

EID: 12344321498     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)61277-X     Document Type: Editorial
Times cited : (6)

References (27)
  • 1
    • 0037387501 scopus 로고    scopus 로고
    • Cross-reacting drugs and chemicals
    • Woessner K. Cross-reacting drugs and chemicals. Clin Rev Allergy Immunol. 2003;24:149-158.
    • (2003) Clin Rev Allergy Immunol , vol.24 , pp. 149-158
    • Woessner, K.1
  • 2
    • 0036676087 scopus 로고    scopus 로고
    • The safety of celecoxib in aspirin exacerbated respiratory disease
    • Woessner K, Simon RA, Stevenson DD. The safety of celecoxib in aspirin exacerbated respiratory disease. Arthritis Rheum. 2002;46:2201-2206.
    • (2002) Arthritis Rheum , vol.46 , pp. 2201-2206
    • Woessner, K.1    Simon, R.A.2    Stevenson, D.D.3
  • 3
    • 0034924476 scopus 로고    scopus 로고
    • Lack of cross-reactivity between rofecoxib and aspirin in aspirin sensitive asthmatic patients
    • Stevenson D, Simon RA. Lack of cross-reactivity between rofecoxib and aspirin in aspirin sensitive asthmatic patients. J Allergy Clin Immunol. 2001;108:47-51.
    • (2001) J Allergy Clin Immunol , vol.108 , pp. 47-51
    • Stevenson, D.1    Simon, R.A.2
  • 4
    • 3042765340 scopus 로고    scopus 로고
    • Sensitivity to aspirin and NSAIDs
    • Adkinson NJ, Yunginger JW, Busse WW, Bochner BS, Holgate ST, Simon FE, editors. Philadelphia, PA: CV Mosby and Co.
    • Stevenson D, Simon RR, Zuraw BL. Sensitivity to aspirin and NSAIDs. In: Adkinson NJ, Yunginger JW, Busse WW, Bochner BS, Holgate ST, Simon FE, editors. Allergy Principles and Practice, 6th ed. Philadelphia, PA: CV Mosby and Co; 2003:1695-1710.
    • (2003) Allergy Principles and Practice, 6th Ed. , pp. 1695-1710
    • Stevenson, D.1    Simon, R.R.2    Zuraw, B.L.3
  • 5
    • 0020055511 scopus 로고
    • Aspirin in chronic urticaria and/or angioedema: Studies of sensitivity and desensitization
    • Mathison DA, Lumry WR, Stevenson DD. Aspirin in chronic urticaria and/or angioedema: studies of sensitivity and desensitization. J Allergy Clin Immunol. 1982;69:135.
    • (1982) J Allergy Clin Immunol , vol.69 , pp. 135
    • Mathison, D.A.1    Lumry, W.R.2    Stevenson, D.D.3
  • 6
    • 0016662061 scopus 로고
    • Reactions to aspirin and food additives in patients with chronic urticaria, including physical urticaria
    • Doeglas H. Reactions to aspirin and food additives in patients with chronic urticaria, including physical urticaria. Br J Dermatol. 1975;93:135-143.
    • (1975) Br J Dermatol , vol.93 , pp. 135-143
    • Doeglas, H.1
  • 7
    • 0019287331 scopus 로고
    • Management of chronic idiopathic urticaria by the identification and exclusion of dietary factors
    • Gibson A, Clancy R. Management of chronic idiopathic urticaria by the identification and exclusion of dietary factors. Clin Allergy. 1980;10:699-705.
    • (1980) Clin Allergy , vol.10 , pp. 699-705
    • Gibson, A.1    Clancy, R.2
  • 9
    • 0348134796 scopus 로고    scopus 로고
    • Safety of COX-2 inhibitors and increased leukotriene synthesis in chronic idiopathic urticaria with sensitivity to NSAIDs
    • Zembowicz AM, Setkowicz M, Radziszewski W, Szczeklik A. Safety of COX-2 inhibitors and increased leukotriene synthesis in chronic idiopathic urticaria with sensitivity to NSAIDs. Arch Dermatol. 2003;139:1577-1582.
    • (2003) Arch Dermatol , vol.139 , pp. 1577-1582
    • Zembowicz, A.M.1    Setkowicz, M.2    Radziszewski, W.3    Szczeklik, A.4
  • 10
    • 1942500163 scopus 로고    scopus 로고
    • Hypersensitivity to aspirin: Common eicosanoid alterations in urticaria and asthma
    • Mastalerz LS, Sanak M, Szczeklik A. Hypersensitivity to aspirin: common eicosanoid alterations in urticaria and asthma. J Allergy Clin Immunol. 2004;113:771-775.
    • (2004) J Allergy Clin Immunol , vol.113 , pp. 771-775
    • Mastalerz, L.S.1    Sanak, M.2    Szczeklik, A.3
  • 11
    • 0038404910 scopus 로고    scopus 로고
    • Intolerance to nonsteroidal anti-inflammatory drugs might precede by years the onset of chronic urticaria
    • Asero R. Intolerance to nonsteroidal anti-inflammatory drugs might precede by years the onset of chronic urticaria. J Allergy Clin Immunol. 2003;111:1095-1098.
    • (2003) J Allergy Clin Immunol , vol.111 , pp. 1095-1098
    • Asero, R.1
  • 12
    • 6044264974 scopus 로고    scopus 로고
    • Safety of the new selective cyclooxygenase 2 inhibitors rofecoxib and celecoxib in patients with anaphylactoid reaction to nonsteroidal anti-inflammatory drugs
    • Quiralte J, Delgado J, Saenz de San Pedro B, et al. Safety of the new selective cyclooxygenase 2 inhibitors rofecoxib and celecoxib in patients with anaphylactoid reaction to nonsteroidal anti-inflammatory drugs. Ann Allergy Asthma Immunol. 2004;93:360-364.
    • (2004) Ann Allergy Asthma Immunol , vol.93 , pp. 360-364
    • Quiralte, J.1    Delgado, J.2    Saenz De San Pedro, B.3
  • 13
    • 12344335531 scopus 로고    scopus 로고
    • Short-term and long-term tolerability of rofecoxib in patients with prior reactions to nonsteroidal anti-inflammatory drugs
    • Nettis E, Colanardi MC, Ferrannini A, Tursi A. Short-term and long-term tolerability of rofecoxib in patients with prior reactions to nonsteroidal anti-inflammatory drugs. Ann Allergy Asthma Immunol. 2005;94:29-33.
    • (2005) Ann Allergy Asthma Immunol , vol.94 , pp. 29-33
    • Nettis, E.1    Colanardi, M.C.2    Ferrannini, A.3    Tursi, A.4
  • 14
    • 12344287988 scopus 로고    scopus 로고
    • Tolerance of nonsteroidal anti-inflammatory drug-sensitive patients to the highly specific cyclooxygenase 2 inhibitors rofecoxib and valdecoxib
    • Sanchez-Borges M, Caballero-Fonseca F, Capriles-Hulett A. Tolerance of nonsteroidal anti-inflammatory drug-sensitive patients to the highly specific cyclooxygenase 2 inhibitors rofecoxib and valdecoxib. Ann Allergy Asthma Immunol. 2005;94:34-38.
    • (2005) Ann Allergy Asthma Immunol , vol.94 , pp. 34-38
    • Sanchez-Borges, M.1    Caballero-Fonseca, F.2    Capriles-Hulett, A.3
  • 15
    • 0016320119 scopus 로고
    • IgE and non-IgE mediated allergic type reactions to aspirin
    • Phils JA, Perlmutter L. IgE and non-IgE mediated allergic type reactions to aspirin. Acta Allergol. 1974;29:474-481.
    • (1974) Acta Allergol , vol.29 , pp. 474-481
    • Phils, J.A.1    Perlmutter, L.2
  • 16
    • 0019470109 scopus 로고
    • Investigation of the possible involvement of IgE antisalicylol antibodies in patients with urticaria
    • Krilis S, Gregson RP, Basten A. Investigation of the possible involvement of IgE antisalicylol antibodies in patients with urticaria. Int Arch Allergy Appl Immunol. 1981;64:293-300.
    • (1981) Int Arch Allergy Appl Immunol , vol.64 , pp. 293-300
    • Krilis, S.1    Gregson, R.P.2    Basten, A.3
  • 17
    • 0036168932 scopus 로고    scopus 로고
    • Urticaria and angioedema induced by COX-2 inhibitors
    • Grimm V, Rakoski J. Urticaria and angioedema induced by COX-2 inhibitors. J Allergy Clin Immunol. 2002;109:370.
    • (2002) J Allergy Clin Immunol , vol.109 , pp. 370
    • Grimm, V.1    Rakoski, J.2
  • 18
    • 0036200326 scopus 로고    scopus 로고
    • Anaphylaxis to celecoxib
    • Grob MP, Wuthrich B. Anaphylaxis to celecoxib. Allergy. 2002;57:264-265.
    • (2002) Allergy , vol.57 , pp. 264-265
    • Grob, M.P.1    Wuthrich, B.2
  • 23
    • 0036228229 scopus 로고    scopus 로고
    • Safety of rofecoxib in subjects with a history of adverse cutaneous reactions to aspirin and/or non-steroidal anti-inflammatory drugs
    • Pacor M, Di Lorenzo G, Biasi D, Barbagallo M, Corrocher R. Safety of rofecoxib in subjects with a history of adverse cutaneous reactions to aspirin and/or non-steroidal anti-inflammatory drugs. Clin Exp Allergy. 2002;32:397-400.
    • (2002) Clin Exp Allergy , vol.32 , pp. 397-400
    • Pacor, M.1    Di Lorenzo, G.2    Biasi, D.3    Barbagallo, M.4    Corrocher, R.5
  • 24
    • 0036127939 scopus 로고    scopus 로고
    • Tolerability of rofecoxib in patient with cutaneous adverse reactions to NSAIDs
    • Nettis ED, Ferrannini A, Tursi A. Tolerability of rofecoxib in patient with cutaneous adverse reactions to NSAIDs. Ann Allergy Asthma Immunol. 2002;88:331-334.
    • (2002) Ann Allergy Asthma Immunol , vol.88 , pp. 331-334
    • Nettis, E.D.1    Ferrannini, A.2    Tursi, A.3
  • 25
    • 0029005688 scopus 로고
    • The effect of aspirin desensitization on urinary leukotriene E4 concentration in aspirin-sensitive asthma
    • Nasser SM, Patel M, Bell GS, Lee TH. The effect of aspirin desensitization on urinary leukotriene E4 concentration in aspirin-sensitive asthma. Am J Respir Crit Care Med. 1995;151:1326-1330.
    • (1995) Am J Respir Crit Care Med , vol.151 , pp. 1326-1330
    • Nasser, S.M.1    Patel, M.2    Bell, G.S.3    Lee, T.H.4
  • 26
    • 0036666451 scopus 로고    scopus 로고
    • Safety of selective cyclooxgenase-2 inhibitor rofecoxib in patients with NSAID-induced cutaneous reactions
    • Quiralte J, Saenz de San Pedro B, Florido JJ. Safety of selective cyclooxgenase-2 inhibitor rofecoxib in patients with NSAID-induced cutaneous reactions. Ann Allergy Asthma Immunol. 2002;89:63-66.
    • (2002) Ann Allergy Asthma Immunol , vol.89 , pp. 63-66
    • Quiralte, J.1    Saenz De San Pedro, B.2    Florido, J.J.3
  • 27
    • 0034866095 scopus 로고    scopus 로고
    • Tolerability of rofecoxib
    • Asero R. Tolerability of rofecoxib. Allergy. 2001;56:916-917.
    • (2001) Allergy , vol.56 , pp. 916-917
    • Asero, R.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.